The purpose of this study is to investigate pancreatic cancer. It focuses on patients who have had surgery to remove the cancer and are at high risk of the disease coming back or spreading.
This study evaluates the outcomes of using chemoradiotherapy compared to chemotherapy. It looks at how these treatments affect patients with specific risk factors after surgery.
- Who can participate: Adults aged 18 to 75 years with pancreatic ductal adenocarcinoma can participate. They must have certain risk factors like lymph node metastasis or specific types of resection. Participants should be in good health with no recent cancer treatments or disease progression.
- Study details: Participants will receive either chemoradiotherapy or chemotherapy after surgery. The study will monitor their health and response to treatment.
How understandable was the trial content above?
Hard to understand
Easy to understand